ENDRA Life Sciences Inc. (NDRA) DCF Valuation

ENDRA Life Sciences Inc. (NDRA) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

ENDRA Life Sciences Inc. (NDRA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial future of ENDRA Life Sciences Inc. (NDRA) with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate the intrinsic value of ENDRA Life Sciences Inc. (NDRA) and enhance your investment strategy.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -10.8 -11.3 -11.0 -12.9 -9.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .2 .2 .2 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -11.0 -11.5 -11.2 -13.2 -10.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 6.2 7.2 9.5 4.9 2.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 -1.3 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .1 .6 1.3 2.6 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.3 .4 .8 .6 .4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 .0 -.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -12.8 -11.7 -11.2 -13.2 -10.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.6 -13.0 -10.0 -16.1 -7.4 -.4 .0 .0 .0 .0
WACC, % 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92 7.92
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -2
Equity Value 2
Diluted Shares Outstanding, MM 9
Equity Value Per Share 0.23

What You Will Get

  • Real NDRA Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust metrics such as WACC, tax rates, revenue growth, and capital expenditures.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Explore various scenarios to assess ENDRA Life Sciences' future performance.
  • User-Friendly Design: Designed for professionals but easy for newcomers to navigate.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical data and future forecasts specific to ENDRA Life Sciences Inc. (NDRA).
  • Adjustable Forecast Parameters: Modify highlighted cells for key inputs like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic adjustments to DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Clear and informative charts and summaries to help visualize your valuation insights.
  • Suitable for All Experience Levels: An easy-to-navigate format designed for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based NDRA DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates ENDRA Life Sciences Inc.'s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the results to inform your investment or financial decisions.

Why Choose This Calculator for ENDRA Life Sciences Inc. (NDRA)?

  • User-Friendly Interface: Tailored for both novices and seasoned users.
  • Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
  • Real-Time Feedback: Observe immediate updates to ENDRA Life Sciences' valuation as you modify inputs.
  • Preloaded Data: Comes with ENDRA Life Sciences' actual financial information for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed decisions.

Who Should Use ENDRA Life Sciences Inc. (NDRA)?

  • Healthcare Investors: Make informed investment choices with cutting-edge healthcare technology insights.
  • Market Analysts: Streamline your analysis with comprehensive data on medical imaging advancements.
  • Consultants: Effortlessly modify presentations or reports tailored to the healthcare sector.
  • Medical Professionals: Enhance your knowledge of innovative imaging solutions and their applications.
  • Educators and Students: Utilize it as a valuable resource for learning about medical technology in academic settings.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled ENDRA Life Sciences Inc. (NDRA) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for ENDRA Life Sciences Inc. (NDRA).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.